The present invention provides a cannulation device for administering an active agent containing composition to the suprachoroidal space or supraciliary space. The invention provides methods of treatment of an ocular disease or condition accordingly. The invention also provides compositions for use in a method of treatment of an ocular disease or condition for delivery into the suprachoroidal space or supraciliary space.
Ophthalmic drug compositions
13.11.2019
Patent
Elektronische Ressource
Englisch
Ophthalmic delivery device and ophthalmic drug compositions
Europäisches Patentamt | 2017
FDA approves faster ophthalmic imager
British Library Online Contents | 1999